Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin + pentoxifylline + vitamin D3 for consciousness in brain injury
IRCT20130812014333N157Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of erythropoietin, pentoxifylline and vitamin d in traumatic brain injury (TBI) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Level of consciousness. Started Jan 2021; status: completed.
02
Drugs
erythropoietinpentoxifyllinevitamin d
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20130812014333N157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N157.